NF-κB and inflammation in genetic disease

被引:57
作者
Sebban, Helene [1 ]
Courtois, Gilles [1 ]
机构
[1] Hop St Louis, INSERM, U697, F-75010 Paris, France
关键词
inflammation; NF-kappa B; incontinentia pigmenti;
D O I
10.1016/j.bcp.2006.08.006
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
By responding to pro-inflammatory cytokines, such as IL-1 beta and TNF-alpha, and controlling itself the expression of numerous mediators of inflammation, NF-kappa B plays a pivotal role in controlling the proper sequence of events characterizing the inflammation process. Although excessive NF-kappa B activation is often associated with inflammatory signs in many different tissues, impaired NF-kappa B activation can also generate inflammation. This is the case in humans suffering from the genetic disease incontinentia pigmenti that exhibit severe skin inflammation. Identifying the molecular basis of this pathology, mutations affecting the gene coding for NEMO, has allowed production of mouse models for investigating the disease. Their characterization supports the view that a very tight positive and negative regulation of the NF-kappa B signaling pathway is required in vivo to ensure not only a fine-tuned response to injury or infection but also to maintain tissue homeostasis. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:1153 / 1160
页数:8
相关论文
共 38 条
[1]
Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-γ) [J].
Aradhya, S ;
Courtois, G ;
Rajkovic, A ;
Lewis, RA ;
Levy, M ;
Israël, A ;
Nelson, DL .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (03) :765-771
[2]
A recurrent deletion in the ubiquitously expressed NEMO (IKK-γ) gene accounts for the vast majority of incontinentia pigmenti mutations [J].
Aradhya, S ;
Woffendin, H ;
Jakins, T ;
Bardaro, T ;
Esposito, T ;
Smahi, A ;
Shaw, C ;
Levy, M ;
Munnich, A ;
D'Urso, M ;
Lewis, RA ;
Kenwrick, S ;
Nelson, DL .
HUMAN MOLECULAR GENETICS, 2001, 10 (19) :2171-2179
[3]
EMBRYONIC LETHALITY AND LIVER DEGENERATION IN MICE LACKING THE RELA COMPONENT OF NF-KAPPA-B [J].
BEG, AA ;
SHA, WC ;
BRONSON, RT ;
GHOSH, S ;
BALTIMORE, D .
NATURE, 1995, 376 (6536) :167-170
[4]
Incontinentia pigmenti: A review and update on the molecular basis of pathophysiology [J].
Berlin, AL ;
Paller, AS ;
Chan, LS .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 47 (02) :169-187
[5]
Late recurrence of inflammatory first-stage lesions in incontinentia pigmenti - An unusual phenomenon and a fascinating pathologic mechanism [J].
Bodak, N ;
Hadj-Rabia, S ;
Hamel-Teillac, D ;
de Prost, Y ;
Bodemer, C .
ARCHIVES OF DERMATOLOGY, 2003, 139 (02) :201-204
[6]
Ubiquitin signalling in the NF-κB pathway [J].
Chen, ZJJ .
NATURE CELL BIOLOGY, 2005, 7 (08) :758-U19
[7]
X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-κB signaling [J].
Döffinger, R ;
Smahi, A ;
Bessia, C ;
Geissmann, F ;
Feinberg, J ;
Durandy, A ;
Bodemer, C ;
Kenwrick, S ;
Dupuis-Girod, S ;
Blanche, S ;
Wood, P ;
Rabia, SH ;
Headon, DJ ;
Overbeek, PA ;
Le Deist, F ;
Holland, SM ;
Belani, K ;
Kumararatne, DS ;
Fischer, A ;
Shapiro, R ;
Conley, ME ;
Reimund, E ;
Kalhoff, H ;
Abinun, M ;
Munnich, A ;
Israël, A ;
Courtois, G ;
Casanova, JL .
NATURE GENETICS, 2001, 27 (03) :277-285
[8]
Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality [J].
Doi, TS ;
Marino, MW ;
Takahashi, T ;
Yoshida, T ;
Sakakura, T ;
Old, LJ ;
Obata, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (06) :2994-2999
[9]
NOD2 and Crohn's disease: Loss or gain of function? [J].
Eckmann, L ;
Karin, M .
IMMUNITY, 2005, 22 (06) :661-667
[10]
Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-κB activation [J].
Fusco, F ;
Bardaro, T ;
Mercadante, V ;
Miano, MG ;
Falco, G ;
Israël, A ;
Courtois, G ;
Ursini, MV .
HUMAN MOLECULAR GENETICS, 2004, 13 (16) :1763-1773